Lafex 37.5mg Tablet ER
Marketer
Solarium Pharmaceuticals
Salt Composition
Venlafaxine (37.5mg)
Overview Lafex 37.5mg Tablet ER
Axilon 37.5mg Extended-Release Tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, unease, poor concentration, tiredness, perspiration, rapid heartbeat, and intrusive thoughts. Take Axilon 37.5mg ER with food at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon remembering. Complete the prescribed course, even if feeling improved; abruptly stopping may worsen symptoms. Possible side effects include queasiness, vomiting, sleep disturbances, reduced appetite, nervousness, bowel irregularity, excessive sweating, and sexual difficulties. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the effects are known. Most side effects are temporary and self-limiting. Consult your physician if side effects persist or are troubling. Prior to starting Axilon 37.5mg ER, disclose any kidney, heart, or liver conditions, or history of seizures to your doctor. Report any unusual mood or behavioral changes, worsening depression, or suicidal ideation immediately.
Primary Ingredients of Lafex 37.5mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Lafex 37.5mg Tablet ER
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Lafex 37.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lafex 37.5mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Lafex 37.5mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Lafex 37.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 37.5mg extended-release Lafex tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.
How Lafex 37.5mg Tablet ER works:
Lafex 37.5mg Extended-Release tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Lafex 37.5mg Extended-Release Tablets.
PregnancyCONSULT YOUR DOCTOR
Extended-release Lafex 37.5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Lafex 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Infants should be observed for drowsiness and monitored for appropriate weight increase.
DrivingUNSAFE
Driving ability may be impaired by Lafex 37.5mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving.
KidneyCAUTION
Patients with kidney impairment should use Lafex 37.5mg Extended-Release tablets cautiously. Dosage modification for Lafex 37.5mg Extended-Release tablets may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Lafex 37.5mg Extended-Release tablets. Dosage modification of Lafex 37.5mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Lafex 37.5mg Tablet ER :
Should you forget a Lafex 37.5mg Extended-Release Tablet, take it immediately. If your next dose is imminent, however, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lafex 37.5mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anisole-based Compound |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |






